Search
Search Results
##search.searchResults.foundPlural##
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1530PDF: 673HTML: 4208 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2182PDF: 2059HTML: 816 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1623PDF: 1437HTML: 126 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4379PDF: 2118HTML: 295 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1126PDF: 604HTML: 355 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1495PDF: 596HTML: 316 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2575PDF: 1111HTML: 1686Fig 1: 294Tab I: 274Cover Letter: 291 -
Pseudo-differentiation syndrome
1584PDF: 758HTML: 10895Figure 1: peripheral blood showing myeloblasts with auer rods: 179Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 153Figure 3: CXR showing pulmonary infiltartes with consolidation: 183Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 162Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 161 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2384PDF: 1121HTML: 4135Cover Letter: 305Figure 1: 303Figure 2: 289Table 1: 279 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4769PDF: 1844HTML: 1451 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
916PDF: 980PDF Supp. Files: 123HTML: 276 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2285PDF: 868HTML: 3296 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1805PDF: 837HTML: 1526 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1561PDF: 913HTML: 8697Fig 3 Savini: 267Fig 2 Savini: 262Fig 1 Savini Chest TC: 245Author letter to referees: 258 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1348PDF: 684HTML: 2935ATRA induced Reactive Hemophagocytosis: A Case Report: 269 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5065PDF: 1936HTML: 2911Untitled: 359 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1139PDF: 589HTML: 761 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
5053PDF: 1980HTML: 2231 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1502PDF: 1162HTML: 498 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4280PDF: 1266HTML: 2140Fig.1: 256Fig. 2: 152Table 1: 266Table2: 295Table 3: 288 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4290PDF: 1373HTML: 2136Table 1: 263 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1823PDF: 1184HTML: 532







